Trailblazer Merger Co. I (NASDAQ:TBMC – Get Free Report) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 800 shares, a decrease of 42.9% from the November 15th total of 1,400 shares. Based on an average daily volume of 16,600 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are short sold.
Trailblazer Merger Co. I Stock Performance
NASDAQ TBMC remained flat at $11.11 on Friday. The company had a trading volume of 5 shares, compared to its average volume of 1,768. The business has a 50-day simple moving average of $11.09 and a 200 day simple moving average of $10.94. Trailblazer Merger Co. I has a 12 month low of $10.42 and a 12 month high of $11.60.
Insider Activity
In other news, major shareholder Aqr Capital Management Holding sold 50,000 shares of the business’s stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $11.02, for a total transaction of $551,000.00. Following the completion of the sale, the insider now owns 580 shares of the company’s stock, valued at $6,391.60. The trade was a 98.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 23.50% of the company’s stock.
Institutional Inflows and Outflows
About Trailblazer Merger Co. I
Trailblazer Merger Corporation I does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.
Recommended Stories
- Five stocks we like better than Trailblazer Merger Co. I
- Insider Buying Explained: What Investors Need to Know
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are Penny Stocks a Good Fit for Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 5 Top Rated Dividend Stocks to Consider
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Trailblazer Merger Co. I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trailblazer Merger Co. I and related companies with MarketBeat.com's FREE daily email newsletter.